Company profile
Bioqual, Inc.
OTC: BIOQ · Healthcare · Medical - Diagnostics & Research
#439 of 1,418 Healthcare companies by revenue29th-percentile growth
EA Score
——FH —DQ —GM —SS 70
v0.1 · 5/100 weight · pillars only
↑ listing tenure, return on assets · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$42.3M
Rev growth YoY (TTM)
-13.6%
Net income (FY)
-$1.0M
Employees
278
as of 2026-08-20
Market cap
$29.1M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$48.9M$48.9M2024
Net income-$1.0M-$1.0M2024
Operating income-$1.9M-$1.9M2024
Total assets$57.1M$57.1M2024
Liabilities$21.0M$21.0M2024
Equity$36.2M$36.2M2024
Revenue trend
FY2017 – FY2024 · USD
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Bioqual, Inc.’s revenue?
Bioqual, Inc. booked $48.9M in FY2024 revenue, contracting 17% year over year — slower than 71% of Healthcare companies we track, at a -2.1% net margin.
Peers · Healthcare
Minerva Surgical, Inc.——Charlotte's Web Holdings, Inc.44DLexicon Pharmaceuticals, Inc.59CGossamer Bio, Inc.24DShoulder Innovations, Inc.42DEvome Medical Technologies Inc.——Neighbors
Montgomery →Key facts
CEOHanne Andersen-Elyard
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersRockville, MD
ExchangeOTC: BIOQ
Employees278
IPO date2002-06-21
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.